Corporations would face more pressure to succeed and thrive if the U.S. Treasury Department increases corporate income taxes by nearly $2.8 trillion, or 56%. While the additional funding aims to improve the lives of lower earners, hiking corporate taxes could slow the economy and reduce some opportunities by burdening businesses already struggling to pay for innovation and growth initiatives. A major tax hike may impede businesses from investing in technology and equipment to improve efficiency and generate higher revenue, which could boost wages and create new jobs.
The fiscal year (FY) 2025 budget reinvigorates efforts to increase the U.S. corporate income tax rate from 21% to 28%, and includes provisions to hike the corporate alternative minimum tax (CAMT) from 15% to 21%, and to raise the corporate stock repurchase excise tax from 1% to 4%. The latter two provisions were enacted as part of the 2022 Inflation Reduction Act. Additional tax proposals would impact corporate and pass-through businesses, increase certain fuel taxes for some private planes, and deny business deductions for employee compensation over $1 million.
The U.S. corporate tax rate has oscillated wildly over time, averaging 32.18% between 1909 and 2023, moving from a low of 1% in 1910 to hitting a high of 52.8% percent in 1968, according to the Internal Revenue Service (IRS). The current rate of 21% was whittled from 35% by the 2017 Tax Cuts and Jobs Act (TCJA).
Here's a look at how much key corporate tax proposals would generate over a decade:
Money raised from U.S. international tax rule reform proposals include:
The funding outlook from additional business tax proposals includes:
Bottom Line: Corporations, along with the highest-earning taxpayers, face the biggest brunt in wide-ranging efforts to reduce the deficit and fund government programs. The outcome depends on which party controls the Congress next year, as well as the margin of control in the House and the Senate. As business leaders engage with policymakers on the impact of potential corporate tax changes, individuals should speak with their financial advisors about how these proposals may impact portfolio allocations and individual tax strategies.
1The TCJA changed the treatment of R&E under Section 174, and taxpayers are now required to capitalize and amortize all R&E that are paid or incurred in connection with their trade or business representing experimental or laboratory costs. U.S.-based R&E activities must be amortized over five years and costs for foreign R&E activities must be amortized over 15 years, both using a midyear convention.
2Subpart F Income involves Controlled Foreign Corporations (CFCs) that accumulate certain types of income, primarily passive income.
3 A wash sale happens when an investor sells a security at a loss and then purchases the same or a substantially similar security within 30 days, before or after the transaction.
Disclaimer
Eaton Vance and Morgan Stanley do not provide legal, tax or accounting advice or services. Clients should consult with their own tax or legal advisor prior to entering into any transaction or strategy.
The views and opinions and/or analysis expressed are those of the author or the investment team as of the date of preparation of this material and are subject to change at any time without notice due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all investment personnel at Morgan Stanley Investment Management (MSIM) and its subsidiaries and affiliates (collectively “the Firm”), and may not be reflected in all the strategies and products that the Firm offers.
Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors or the investment team. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific strategy or product the Firm offers. Future results may differ significantly depending on factors such as changes in securities or financial markets or general economic conditions.
This material has been prepared on the basis of publicly available information, internally developed data and other third-party sources believed to be reliable. However, no assurances are provided regarding the reliability of such information and the Firm has not sought to independently verify information taken from public and third-party sources.
This material is a general communication, which is not impartial and all information provided has been prepared solely for informational and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.
Charts and graphs provided herein are for illustrative purposes only. Past performance is no guarantee of future results. The indexes are unmanaged and do not include any expenses, fees or sales charges. It is not possible to invest directly in an index. Any index referred to herein is the intellectual property (including registered trademarks) of the applicable licensor. Any product based on an index is in no way sponsored, endorsed, sold or promoted by the applicable licensor and it shall not have any liability with respect thereto.